PF-3429281 – A novel inhaled dual antimuscarinic/β2 adrenoceptor agonist in the anaesthetised dog model of bronchoconstriction

K. Wright, N. Clarke, M. Yeadon, C. Perros-Huguet (Sandwich, United Kingdom)

Source: Annual Congress 2010 - Bronchodilators in airways disease
Session: Bronchodilators in airways disease
Session type: Oral Presentation
Number: 5559
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
K. Wright, N. Clarke, M. Yeadon, C. Perros-Huguet (Sandwich, United Kingdom). PF-3429281 – A novel inhaled dual antimuscarinic/β2 adrenoceptor agonist in the anaesthetised dog model of bronchoconstriction. Eur Respir J 2010; 36: Suppl. 54, 5559

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
PF-00610355 – an inhaled β2 adrenoceptor agonist with superior potency and duration of action (DoA) to salmeterol in the conscious dog model of bronchoconstriction
Source: Annual Congress 2009 - Models of chronic airways disease and therapy
Year: 2009

The in-vitro pharmacology of PF-3429281 – A novel inhaled dual antimuscarinic/β2 adrenoceptor agonist
Source: Annual Congress 2010 - Regulation of airway hyperresponsiveness and bronchodilators
Year: 2010

Effects of intratracheal pf-00610355, an inhaled β2 adrenoceptor agonist, in anaesthetised animals
Source: Annual Congress 2009 - New bronchodilators
Year: 2009

Synergistic bronchoprotective activity of the long-acting beta 2-agonist olodaterol with tiotropium (long-acting M3 antagonist) and ciclesonide (inhaled steroid) on the ovalbumin-induced bronchoconstriction in anaesthetized guinea pigs
Source: Annual Congress 2011 - Understanding disease and drug mechanisms
Year: 2011


The in vitro biology of PF-00610355 – a novel β2 adrenoceptor agonist with a long duration of action
Source: Annual Congress 2009 - Models of chronic airways disease and therapy
Year: 2009

A novel dual-agonist challenge model in guinea pigs for assessment of individual and combined muscarinics antagonists and b2 adrenoceptor agonists bronchodilator efficacy
Source: Annual Congress 2011 - Models of disease and drug actions
Year: 2011

Nebulized bimosiamose – anti-inflammatory pan-selectin antagonist for the treatment of COPD
Source: Annual Congress 2009 - Treatment of airways disease
Year: 2009

The in-vitro pharmacology of PF-4522971 – A novel inhaled Muscarinic M3 Antagonist
Source: Annual Congress 2010 - Regulation of airway hyperresponsiveness and bronchodilators
Year: 2010

Compound X – an inhaled β2 agonist with equivalent potency and superior duration of action (DOA)/ therapeutic index (TI) to salmeterol in the anaesthetised dog model of bronchoconstriction
Source: Annual Congress 2008 - Novel treatments for respiratory disease
Year: 2008

Safety and toleration of pf-00610355, a novel inhaled long acting β2 adrenoreceptor agonist
Source: Annual Congress 2009 - New bronchodilators
Year: 2009

Alpha-1L, but not alpha-1H, adrenoceptor antagonist prevents allergic bronchoconstriction in guinea pigs in vivo
Source: Eur Respir J 2001; 18: Suppl. 33, 104s
Year: 2001

Vilanterol, a novel inhaled long-acting β2 adrenoceptor agonist (LABA), demonstrates extensive first pass clearance to metabolites with negligible pharmacological activity in man
Source: Annual Congress 2011 - Drug delivery and pharmacokinetics I
Year: 2011

Demonstration of dual pharmacology in vivo of PF-3429281: A novel inhaled dual antimuscarinic/β2 agonist
Source: Annual Congress 2010 - Regulation of airway hyperresponsiveness and bronchodilators
Year: 2010

Influence of the long-acting beta 2-agonist indacaterol on the citric acid-induced cough model in conscious guinea pigs
Source: Annual Congress 2010 - Regulation of airway hyperresponsiveness and bronchodilators
Year: 2010


Abediterol has higher bronchodilatory potency than other long-acting beta2-receptor agonists in a guinea pig model
Source: International Congress 2014 – Novel evidence relating to respiratory treatment development
Year: 2014

Potency and duration of action of R,R-glycopyrrolate (RRG) on acetylcholine (ACh) induced bronchoconstriction as compared to tiotropium (TIO) in unrestrained conscious mice
Source: Eur Respir J 2005; 26: Suppl. 49, 217s
Year: 2005

Repeated-dose pharmacokinetics of once-daily TD-4208, a long-acting muscarinic receptor antagonist (LAMA), in subjects with COPD
Source: International Congress 2014 – Bronchodilators for asthma and COPD
Year: 2014


Pharmacokinetics of PF-00610355, a novel inhaled long-acting β2-adrenoreceptor agonist
Source: Annual Congress 2009 - Next generation bronchodilators
Year: 2009


Bitter taste receptor agonists as a novel class of bronchodilators in guinea-pig airways
Source: Annual Congress 2011 - Translational models of airway disease
Year: 2011

Tracheal responsiveness to isoprenaline and beta2-adrenoreceptor blockade by propranolol in cigarette smoke exposed and sensitized guinea pigs
Source: Annual Congress 2008 - Cough and airway hyperresponsiveness
Year: 2008